# Phase 1 Placebo Controlled Study of the Safety, Activity and Pharmacokinetics of HQK-1001 in Healthy Subjects

> **NCT00717262** · PHASE1 · COMPLETED · sponsor: **HemaQuest Pharmaceuticals Inc.** · enrollment: 41 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** HQK-1001
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00717262
- **Lead sponsor:** HemaQuest Pharmaceuticals Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2008-08
- **Final completion:** 2008-09
- **Target enrollment:** 41 (ESTIMATED)
- **Last updated:** 2009-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00717262

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00717262, "Phase 1 Placebo Controlled Study of the Safety, Activity and Pharmacokinetics of HQK-1001 in Healthy Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00717262. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*